GLP-1 drugs linked to fewer heart complications and infections after surgery

· Health

People taking GLP-1 medications, which are widely prescribed for diabetes and weight loss, had lower rates of major heart-related complications and infections after surgery than people not taking the drugs, according to study results presented at the ANESTHESIOLOGY 2026 annual meeting. The findings extend the debate over GLP-1 drugs beyond weight loss and diabetes control into perioperative safety, an area where anesthetists have been weighing questions about stomach emptying and aspiration risk. The report did not detail the size of the study population or the magnitude of the effect. If confirmed, the results would be relevant to the large and growing group of surgical patients who already use these medicines, and to the anesthesia teams planning their care.

Why it matters：GLP-1 drugs are now used by a large share of surgical patients, so evidence on how they affect perioperative outcomes could reshape anesthesia protocols and pre-surgery medication guidance.

Key points

  • Results were presented at the ANESTHESIOLOGY 2026 annual meeting.
  • The study compared surgical patients taking GLP-1 drugs with those not taking them.
  • The class is widely prescribed for diabetes and weight loss.

Sources (original reporting)

More stories from this day